Convalescent Plasma for Patients With COVID-19: A Pilot Study
Sponsor: CES University
Listed as NCT04332380, this PHASE2 trial focuses on Coronavirus and Coronavirus Infection and remains completed. Sponsored by CES University, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Not Yet Recruiting → Completed
-
May 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CES University
- Fundación Universitaria de Ciencias de la Salud
- Instituto Distrital de Ciencia Biotecnologia e Innovacion en salud
- Universidad del Rosario
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bogota, Colombia